Lenvatinib for Liver Cancer Approved in Europe Lenvatinib for Liver Cancer Approved in Europe
The European Commission granted marketing authorization to lenvatinib as first-line treatment in advanced or unresectable hepatocellular carcinoma.International Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Hematology | Hepatocellular Carcinoma | Liver | Liver Cancer | Marketing | Urology & Nephrology